Article
Plasma total homocysteine levels and methylenetetrahydrofolate reductase gene polymorphism in patients with type 2 diabetes mellitus.
Pathophysiology of haemostasis and thrombosis - 1 Jan 2008
Soares Anna L, Fernandes Ana P, Cardoso Jarbas E, Sousa Marinez O, Lasmar Marcelo C, Novelli Bethânia A, Lages Geralda F, Dusse Luci M, Vieira Lauro M, Lwaleed Bashir A, Carvalho Maria G
Abstract excerpt
BACKGROUND: Thrombotic episodes account for approximately 80% of deaths in type 2 diabetic patients. Hyperhomocysteinaemia is a well recognized independent risk factor for atherosclerosis and thromboembolism. Increased homocysteine levels may occur due to a number of factors including inherited gene polymorphism of methylenetetrahydrofolate reductase (MTHFR) C677T. Here, we evaluate plas- ma total homocysteine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
